A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release

Huan Yang1, Hulda Hreggvidsdottir2, Karin Palmblad3, Haichao Wang4, Mahendar Ochani5, Jianhua Li5, Ben Lü5, Sangeeta S. Chavan5, Mauricio Rosas‐Ballina5, Yousef Al‐Abed6, Shizuo Akira7, Angelika Bierhaus8, Helena Erlandsson-Harris2, Ulf Andersson5,3, Kevin J. Tracey5,3
1Laboratory of Biomedical Science and Department of Medicinal Chemistry, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA.
2Departments of bMedicine and
3Women's and Children's Health, Karolinska Institute, 17176 Stockholm, Sweden;
4Department of Emergency Medicine, North Shore University Hospital, Manhasset, NY 11030;
5Laboratory of Biomedical Science and
6Department of Medicinal Chemistry, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030; Departments of b Medicine and
7Laboratory of Host Defense, WPI Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan; and
8Department of Medicine and Clinical Chemistry, University of Heidelberg, 69120 Heidelberg, Germany

Tóm tắt

During infection, vertebrates develop “sickness syndrome,” characterized by fever, anorexia, behavioral withdrawal, acute-phase protein responses, and inflammation. These pathophysiological responses are mediated by cytokines, including TNF and IL-1, released during the innate immune response to invasion. Even in the absence of infection, qualitatively similar physiological syndromes occur following sterile injury, ischemia reperfusion, crush injury, and autoimmune-mediated tissue damage. Recent advances implicate high-mobility group box 1 (HMGB1), a nuclear protein with inflammatory cytokine activities, in stimulating cytokine release. HMGB1 is passively released during cell injury and necrosis, or actively secreted during immune cell activation, positioning it at the intersection of sterile and infection-associated inflammation. To date, eight candidate receptors have been implicated in mediating the biological responses to HMGB1, but the mechanism of HMGB1-dependent cytokine release is unknown. Here we show that Toll-like receptor 4 (TLR4), a pivotal receptor for activation of innate immunity and cytokine release, is required for HMGB1-dependent activation of macrophage TNF release. Surface plasmon resonance studies indicate that HMGB1 binds specifically to TLR4, and that this binding requires a cysteine in position 106. A wholly synthetic 20-mer peptide containing cysteine 106 from within the cytokine-stimulating B box mediates TLR4-dependent activation of macrophage TNF release. Inhibition of TLR4 binding with neutralizing anti-HMGB1 mAb or by mutating cysteine 106 prevents HMGB1 activation of cytokine release. These results have implications for rationale, design, and development of experimental therapeutics for use in sterile and infectious inflammation.

Từ khóa


Tài liệu tham khảo

10.1084/jem.192.4.565

10.1126/science.285.5425.248

10.1073/pnas.2434651100

10.1002/eji.200424916

10.1038/nri1594

10.1016/j.bbagrm.2009.11.019

10.1016/j.bbagrm.2009.11.003

10.1084/jem.20042614

10.1111/j.1600-065X.2007.00579.x

10.1097/01.shk.0000225404.51320.82

10.1074/jbc.M306793200

10.1152/ajpcell.00401.2005

10.1038/nm1622

10.1038/ni1457

10.1126/science.1168988

10.1007/BF03402105

10.1097/01.CCM.0000259534.68873.2A

10.1002/art.10540

10.2119/2006-00108.Goldstein

10.1038/nature00858

10.1084/jem.20052203

10.1038/nmeth947

10.1016/j.immuni.2008.05.013

10.1016/j.jim.2004.04.019

10.1189/jlb.0506349

10.4049/jimmunol.178.6.3856

10.1172/JCI200418704

K Hoshino, et al., Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162, 3749–3752 (1999).

10.1016/S1074-7613(00)80119-3